# Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial

> **NCT02661477** · PHASE2 · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Rhinovirus Infection

## Interventions

- **DRUG:** pegylated interferon alfa 2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02661477
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661477, "Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02661477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*